Medication info
Dapaglim Tablets 5 mg (Dapagliflozin Propanediol Hydrate)

Dapaglim Tablets 5 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Mother's Pharmaceutical Co., Ltd.
Appearance
Yellow, round, convex film-coated tablets
Packaging
28 tablets/box [(14 tablets/PTP x 2)]
Approval status
Active

MFDS item code 202300412 · Approved 2023.01.31 · Insurance code 622805010

Summary

Main use
Treatment of type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug therapy who are receiving this medicine in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not use this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Mother's Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease

  • Type 2 diabetes
  • blood glucose control disorders
  • chronic heart failure
  • cardiovascular diseases
  • chronic kidney disease
  • estimated decrease in glomerular filtration rate
  • end-stage kidney disease
View approved original text

This medication is used alongside diet and exercise to assist blood glucose control in patients with type 2 diabetes and may be applied as monotherapy or in combination therapy. Additionally, in patients with chronic heart failure, it is administered in conjunction with existing therapies to reduce the risk of death or hospitalization due to cardiovascular diseases. For patients with chronic kidney disease, it is used with standard treatments to help lower the risk of kidney function deterioration and cardiovascular disease. This drug is effectively used for the treatment of major chronic diseases and risk reduction.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug therapy who are receiving this medicine in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not use this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication may not be used in certain patients. For example, individuals with allergies to the active ingredients or excipients should not take it. It is also not indicated for patients with type 1 diabetes or diabetic ketoacidosis. Patients with lactose intolerance or specific genetic metabolic disorders should not use this drug. It is recommended that patients undergoing dialysis do not use this medication. Caution is required for patients with decreased fluid volume or impaired kidney function. This drug may lower blood pressure and can cause a reduction in intravascular fluid volume, leading to hypotension or kidney damage. Special attention is needed for the elderly, those with poor kidney function, or patients taking diuretics. Prior to starting this medication, fluid status and kidney function should be assessed, and symptoms of hypotension and renal function should be monitored regularly during treatment. Blood glucose control effects may vary with kidney function; thus, it is not recommended for patients with severely impaired kidney function. The medication may lead to infections such as genital infections and urinary tract infections, particularly in women or those with a history of infections. Hypoglycemia symptoms may arise, especially when taken with insulin or sulfonylureas, increasing the risk. Signs of dehydration or hypotension due to decreased fluid volume may occur; if these symptoms occur, it is essential to consult a healthcare provider immediately. Rarely, a serious metabolic disorder known as diabetic ketoacidosis may develop, requiring urgent medical attention if symptoms such as vomiting, abdominal pain, or difficulty breathing occur. This medication may occasionally cause serious infections such as necrotizing fasciitis; immediate treatment is necessary if there is pain, swelling, or fever around the genital area. Pregnant or breastfeeding women are advised not to use this drug. Caution should be taken particularly when used by the elderly or those with impaired liver or kidney function, with regular tests required before and after use. This drug may interact with other medications, so it is crucial to inform healthcare professionals about all medications being taken. There is no specific antidote for overdose, so immediate treatment at a medical institution is essential. Finally, caution should be exercised while driving or operating machinery, as there is a risk of hypoglycemia.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased renal creatinine clearance in the early treatment phase, dyslipidemia, elevated serum creatinine in the early treatment phase, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, gastroesophageal reflux disease, epigastric pain, diverticulosis, bowel perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, paresthesia, nerve compression, sinusitis, diverticulitis, pelvic inflammatory disease, pneumonia, pulmonary tuberculosis, uroseptic shock, acute kidney injury, renal dysfunction, chest pain, urgency incontinence, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, urinary stones, increased blood lactate, lymphocytopenia, vitamin D deficiency, dysgeusia, drowsiness, tension headache, carpal tunnel syndrome, cerebral infarction, diabetic neuropathy, loss of consciousness, neuralgia, peripheral neuropathy, sleep disturbance, syncope, tremor, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, flu-like syndrome, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, xeroderma, allergic dermatitis, contact dermatitis, diabetic foot ulcer, sweating abnormalities eczema, coin eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius in a room.

Appearance and packaging

Appearance

Yellow, round, convex film-coated tablets

Package unit

28 tablets/box [(14 tablets/PTP x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.